BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12393503)

  • 1. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.
    Mao X; Orchard G; Lillington DM; Russell-Jones R; Young BD; Whittaker SJ
    Blood; 2003 Feb; 101(4):1513-9. PubMed ID: 12393503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS.
    Mao X; Orchard G; Mitchell TJ; Oyama N; Russell-Jones R; Vermeer MH; Willemze R; van Doorn R; Tensen CP; Young BD; Whittaker SJ
    J Cutan Pathol; 2008 Oct; 35(10):899-910. PubMed ID: 18494816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.
    Mao X; Orchard G; Russell-Jones R; Whittaker S
    Br J Dermatol; 2007 Nov; 157(5):914-21. PubMed ID: 17725669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.
    Mao X; Orchard G; Lillington DM; Russell-Jones R; Young BD; Whittaker S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):176-85. PubMed ID: 12696066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.
    Mao X; Orchard G; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    J Invest Dermatol; 2006 Jun; 126(6):1388-95. PubMed ID: 16614728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis.
    Mao X; Lillington D; Child F; Russell-Jones R; Young B; Whittaker S
    Genes Chromosomes Cancer; 2002 Oct; 35(2):144-55. PubMed ID: 12203778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement.
    Mao X; Onadim Z; Price EA; Child F; Lillington DM; Russell-Jones R; Young BD; Whittaker S
    J Invest Dermatol; 2003 Sep; 121(3):618-27. PubMed ID: 12925224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
    Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
    J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
    Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
    J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.
    Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP
    J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOX expression in different subtypes of cutaneous lymphoma.
    Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T-cell lymphoma.
    Yamaguchi M; Morizane S; Hamada T; Miyake T; Sugaya M; Iwata H; Fujii K; Haramoto-Shiratsuki R; Nakagawa Y; Miura M; Ohshima K; Morishita K; Takahashi T; Imada M; Okada K; Uehara J; Sowa-Osako J; Iwatsuki K
    J Dermatol; 2019 Nov; 46(11):967-977. PubMed ID: 31515833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-mycosis fungoides cutaneous lymphomas in a referral center in Taiwan: A retrospective case series and literature review.
    Liu KL; Tsai WC; Lee CH
    PLoS One; 2020; 15(1):e0228046. PubMed ID: 31978091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
    Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
    J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
    Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
    Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.
    Mao X; Lillington D; Scarisbrick JJ; Mitchell T; Czepulkowski B; Russell-Jones R; Young B; Whittaker SJ
    Br J Dermatol; 2002 Sep; 147(3):464-75. PubMed ID: 12207585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.